Tackling Class A drugs, including synthetic opioids, is a priority for the Government and through our 10 year drugs strategy \u2018From Harm to Hope\u2019 we are taking action to tackle drugs supply and reduce demand.<\/p>
UK agencies are highly alert to the threat from synthetic drugs, including synthetic opioids like fentanyl and nitazenes, as well as synthetic cannabinoids and benzodiazepines. We assess that the scale of trafficking of synthetic opioids into the UK remains low. However, nitazenes, a type of synthetic opioid, have sadly been linked to more than 100 deaths in the UK during the last year, and we are taking action.<\/p>
The cross-Government Synthetic Opioids Taskforce is working with partners, such as the NCA, the Department for Health and Social Care and the National Police Chiefs Council to deliver an evidence-based response to the risk posed by synthetic opioids, and to implement effective action to stem the demand and supply of these dangerous substances.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2024-05-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-02T15:55:34.363Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2024-04-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, what assessment he has made of trends in the levels of synthetic drugs in circulation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"} } , "tablingMemberConstituency" : {"_value" : "York Central"} , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"} ], "uin" : "23765"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }